SCHEMBL13887384

SCHEMBL13887384

COc1ccc(-c2ccc(C#Cc3ccc4[nH]c(NC(C)C)nc4c3)nc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 7/20 0.48
▸ ACACB O00763 5/20 0.47
▸ SCN10A Q9Y5Y9 1/20 0.39
▸ CYP2D6 P10635 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ PDGFRB P09619 1/20 0.37
▸ PDGFRA P16234 1/20 0.37
▸ NPC1 O15118 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ GRM5 P41594 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ GRIN1 Q05586 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13887369 0.89 ACACB (0.45) MCHR1ACACBSCN10ACYP2D6CHRM1
SCHEMBL13887314 0.88 MCHR1 (0.44) MCHR1ACACBCYP2D6CHRM1HTR2A
SCHEMBL13887363 0.88 ACACB (0.46) MCHR1ACACBSCN10AGRM5
SCHEMBL13887378 0.85 DGAT1 (0.45) MCHR1ACACB
SCHEMBL13887380 0.82 MCHR1 (0.55) MCHR1ACACBCYP2D6CHRM1HTR2A
SCHEMBL13887382 0.82 MCHR1 (0.49) MCHR1ACACBSCN10ACYP2D6CHRM1
SCHEMBL13895016 0.81 MAPK1 (0.39) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL13887327 0.81 MCHR1 (0.44) MCHR1ACACBCYP2D6CHRM1HTR2A
SCHEMBL13887332 0.80 MCHR1 (0.41) MCHR1ACACBCYP2D6CHRM1HTR2A
SCHEMBL13887336 0.79 MCHR1 (0.40) MCHR1ACACBCYP2D6CHRM1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524862-B2 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-28 — — US disclosed
Send feedback